OTC Markets EXMKT - Delayed Quote USD
Rennova Health, Inc. (RNVA)
At close: November 15 at 3:00 PM EST
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Seamus Lagan | President, CEO, Interim CFO & Director | 424.5k | -- | 1969 |
Ms. Karen Taylor | Director of Human Resources | -- | -- | -- |
Mr. Sebastien Sainsbury | Company Secretary & Public Relations | 96.67k | -- | -- |
Ms. Kristine Dymond | Treasurer | -- | -- | -- |
Rennova Health, Inc.
400 South Australian Avenue
Suite 800
West Palm Beach, FL 33401
United States
- Sector:?
- Healthcare
- Industry:? Diagnostics & Research
- Full Time Employees:?
- 85
Description
Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. It owns one operating hospital in Oneida, Tennessee; and a rural clinic in Williamsburg, Kentucky. The company is based in West Palm Beach, Florida.
Corporate Governance
Rennova Health, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Related Tickers
ICBU iMD Companies, Inc.
0.0053
-19.70%
BIAF bioAffinity Technologies, Inc.
1.3100
-1.50%
8VP1.F Avricore Health Inc.
0.0345
0.00%
SZLSF StageZero Life Sciences Ltd.
0.0244
0.00%
SZLS.TO StageZero Life Sciences Ltd.
0.0400
0.00%
STRR Star Equity Holdings, Inc.
3.1699
+3.59%
IZOZF Izotropic Corporation
0.0430
0.00%
GENE Genetic Technologies Limited
0.7650
0.00%
AVCR.V Avricore Health Inc.
0.0600
-57.14%
ISPC iSpecimen Inc.
4.2000
-3.45%